Related Experiment Video
Updated: Jul 18, 2025

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Association Between Diabetes, Chronic Kidney Disease, and Outcomes in People With Heart Failure From Asia
Claire A Lawson1,2, Wan Ting Tay3, Lizelle Bernhardt1
1Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom.
Insights
Combined diabetes mellitus (DM) and chronic kidney disease (CKD) significantly worsen outcomes in heart failure (HF) patients, regardless of HF type. CKD consistently predicts poorer results, highlighting the need for integrated management strategies.
Area of Science:
- Cardiology
- Nephrology
- Endocrinology
Background:
- Heart failure (HF), diabetes mellitus (DM), and chronic kidney disease (CKD) are prevalent and interconnected conditions, particularly in Asian populations.
- The combined impact of DM and CKD on HF outcomes, stratified by HF subtype, remains incompletely understood.
Purpose of the Study:
- To investigate the associations between DM, CKD, and their combination with clinical outcomes in patients with heart failure with preserved ejection fraction (HFpEF) versus heart failure with reduced ejection fraction (HFrEF).
Main Methods:
- Analysis of the multinational ASIAN-HF registry data involving 5,239 HF patients.
- Stratification of patients into groups: DM only, CKD only, and combined DM+CKD.
- Evaluation of associations with 1-year composite of mortality or HF hospitalization and Kansas City Cardiomyopathy Questionnaire (KCCQ) scores, analyzed by HF subtype.
Main Results:
- The combination of DM and CKD was associated with increased 1-year mortality or HF hospitalization in both HFrEF (aHR: 2.07) and HFpEF (HR: 2.37).
- In HFrEF, DM only and CKD only also increased risk (aHRs: 1.43). In HFpEF, CKD only increased risk (HR: 2.54), but DM only did not (HR: 1.01).
- Patients with DM+CKD exhibited significantly lower KCCQ scores compared to those without DM or CKD in both HF subtypes.
Conclusions:
- The coexistence of DM and CKD adversely impacts HF outcomes, irrespective of ejection fraction.
- CKD emerges as a consistent predictor of worse outcomes in HF patients with comorbidities.
- Urgent development of strategies for the prevention and management of DM and CKD in HF populations is crucial.
Background:
Diabetes mellitus (DM), chronic kidney disease (CKD), and heart failure (HF) are pathophysiologically linked and increasing in prevalence in Asian populations, but little is known about the interplay of DM and CKD on outcomes in HF.
Objectives:
This study sought to investigate outcomes in patients with heart failure with preserved ejection fraction (HFpEF) vs heart failure with reduced ejection fraction (HFrEF) in relation to the presence of DM and CKD.
Methods:
Using the multinational ASIAN-HF registry, we investigated associations between DM only, CKD only, and DM+CKD with: 1) composite of 1-year mortality or HF hospitalization; and 2) Kansas City Cardiomyopathy Questionnaire scores, according to HF subtype.
Results:
In 5,239 patients with HF (74.6% HFrEF, 25.4% HFpEF; mean age 63 years; 29.1% female), 1,107 (21.1%) had DM only, 1,087 (20.7%) had CKD only, and 1,400 (26.7%) had DM+CKD. Compared with patients without DM nor CKD, DM+CKD was associated with 1-year all-cause mortality or HF hospitalization in HFrEF (adjusted HR: 2.07; 95% CI: 1.68-2.55) and HFpEF (HR: 2.37; 95% CI: 1.40-4.02). In HFrEF, DM only and CKD only were associated with 1-year all-cause mortality or HF hospitalization (both HRs: 1.43; 95% CI: 1.14-1.80), while in HFpEF, CKD only (HR: 2.54; 95% CI: 1.46-4.41) but not DM only (HR: 1.01; 95% CI: 0.52-1.95) was associated with increased risk (interaction P < 0.01). Adjusted Kansas City Cardiomyopathy Questionnaire scores were lower in patients with DM+CKD (HFrEF: mean 60.50, SEM 0.77, HFpEF: mean 70.10, SEM 1.06; P < 0.001) than with no DM or CKD (HFrEF: mean 66.00, SEM 0.65; and HFpEF: mean 75.80, SEM 0.99).
Conclusions:
Combined DM and CKD adversely effected outcomes independently of HF subtype, with CKD a consistent predictor of worse outcomes. Strategies to prevent and treat DM and CKD in HF are urgently required.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Heart Failure Drugs: Diuretics
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Heart Failure I: Introduction

